Principal Investigators

    Kaj Blennow


    Gothenborg University

    Contact information of lead PI



    Title of project or programme

    Alzheimers sjukdom – biomarkörer för molekylära mekanismer, diagnostik och theragnostik. Alzheimer's disease - biomarkers for molecular mechanisms, diagnostics and theragnostics

    Source of funding information

    The Swedish Brain Foundation

    Total sum awarded (Euro)

    € 108,814

    Start date of award


    Total duration of award in years



    Research Abstract

    We have developed an efficient strategy to identify novel biomarkers by targeted proteomics, develop novel immunoassays or MS based assays, make a thorough neurochemical validation of the biomarker and finally validate their clinical and pathogenic performance. We also have a long lasting experience in transferring biomarker assays to clinical routine and implement them in clinical trials. Thus, we are very optimistic that this project will result in novel valuable biomarkers for AD. In future clinical routine, novel CSF biomarkers for the central pathologies together with knowledge on the temporal sequence of pathologic events will also facilitate the selection of individuals that will be most likely to
    respond to a new disease-modifying therapy directed against a specific pathology. Blood biomarkers will be highly valuable as screening tools in primary care, to allow selection of patients for admission to the specialist clinic.

    Further information available at:

Types: Investments < €500k
Member States: Sweden
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF